Eyenovia (EYEN) IPO Opens Flat

Today's IPO for Eyenovia Inc. (NASDAQ: EYEN) opened for trading at $10 after pricing its initial public offering of 2,730,000 shares of common stock at a price of $10.00 per share.

In addition, Eyenovia has granted the underwriters a 30-day option to purchase up to an additional 409,500 shares of common stock at the initial public offering price, less the underwriting discounts and commission, to cover overallotments if any.

Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc. (NYSE American: LTS) and Roth Capital Partners are acting as joint book-running managers for the offering.

Eyenovia is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for micro-therapeutics. Eyenovia’s pipeline is currently focused on the late-stage development of micro-therapeutics for glaucoma and other eye diseases.

You May Also Be Interested In

• Neo-Concept International Group Holdings (NCI) Prices 2.32M Share IPO at $4/sh
• RMG Acquisition Corp. III (RMGCU) Cancels Dissolution
• Recent IPO Top Wealth Group (TWG) trading 90% higher